| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/26/2011 | CN101336975B Traditional Chinese medicine ointment for treating dermatophytosis |
| 01/26/2011 | CN101279018B Chinese medicine naoxueshu preparations |
| 01/26/2011 | CN101273981B Preparation and method for treating diabetes |
| 01/26/2011 | CN101270101B Method for preparing potassium sodium dehydroandroan drographolide succinate for injection and its freeze-dried injection |
| 01/26/2011 | CN101249219B Paste for curing idiopathic facial nerve paralysis disease and preparation method thereof |
| 01/26/2011 | CN101240002B Fatty acylaminoacylcytarabine conjugate, preparation method and application thereof |
| 01/26/2011 | CN101237852B Liquid formulations |
| 01/26/2011 | CN101234188B Pharmaceutical composition for treating pain and preparation thereof |
| 01/26/2011 | CN101224280B Lick brick for treating animal nutrient metabolism disease |
| 01/26/2011 | CN101224237B Novel uses of compound seabuckthorn seed oil in preparing medicine |
| 01/26/2011 | CN101214280B Chinese medicine for treating burn, scald and sores and preparation thereof |
| 01/26/2011 | CN101199790B Chinese medicine for treating asthma |
| 01/26/2011 | CN101185640B Lomoxicam sustained release tablet and preparation method thereof |
| 01/26/2011 | CN101181235B Tantudinun sustained-release implantation agent for curing entity tumour |
| 01/26/2011 | CN101181231B Sustained-release implantation agent of urotrotiken |
| 01/26/2011 | CN101167974B Quality control method of 'xuhanting' preparation |
| 01/26/2011 | CN101095950B Hydrophobia vaccine freezing drying preparations for stable human beings and the preparations thereof |
| 01/26/2011 | CN101085270B Vein-relaxing damp-dispelling capsule |
| 01/26/2011 | CN101066259B Solid dispersion of higher fatty alcohol and its prepn |
| 01/26/2011 | CN101058561B Diphenylurea derivative for inhibiting protein kinase, and composition and use thereof |
| 01/26/2011 | CN101045063B Clarithromycin water soluble preparation for injection use |
| 01/26/2011 | CN101019945B Hepatitis treating Chinese medicine composition soft capsule |
| 01/26/2011 | CN101002849B Traditional Chinese medicine extractive or tablet for treating hepatitis, and its preparing method |
| 01/25/2011 | USRE42072 High transport rates of hormones delivered across cell membranes, facilitating more efficient delivery of drugs and diagnostic agents by using a viscous fluid comprising a polysaccharide a form of hydrogel, lipogel or sols; drug delivery to mucous membranes; gastrointesinal systems |
| 01/25/2011 | US7875697 Poly(orthoester) polymers, and methods of making and using same |
| 01/25/2011 | US7875677 Micellar drug delivery systems for hydrophobic drugs |
| 01/25/2011 | US7875651 Epicatechin for hypertension treatment |
| 01/25/2011 | US7875590 using an injectable or implantable rod-shaped formulation for delivery of osteogenic proteins to treat osteoporotic and/or osteopenic bone; bone morphogenic proteins |
| 01/25/2011 | US7875588 Methods of therapy using pharmaceutical composition for thrombin peptide derivatives |
| 01/25/2011 | US7875310 Residual solvent extraction method and microparticles produced thereby |
| 01/25/2011 | US7875306 Completely-soluble solid particle(s) based on dietary fibre(s) |
| 01/25/2011 | US7875297 administering to the uterine cavity a plurality of physiologically inert beads bearing a tissue necrosing amount of silver nitrate as a solid silver ion source; |
| 01/25/2011 | US7875295 High shear precipitation; faster, higher yield of microparticles or nanoparticles |
| 01/25/2011 | US7875294 applying a hydrophilic foam ( isophoron diisocyanate end capped polyoxyethylene glycol) substrate and a polymeric hydrophilic agent ( starach grafted copolymer of acrylic acid-acylamide sodium salt) to a portion of the surface of bruised skin reduce the severity of bruising (result of surgery, injury) |
| 01/25/2011 | US7875293 Biointerface membranes incorporating bioactive agents |
| 01/25/2011 | US7875292 Orally disintegrable tablets |
| 01/25/2011 | US7875291 Nutritional supplement, for managing metabolic disorders; first formulation including minerals e.g magnesium glycinate, manganese sulfate, selenium, vanadyl sulfate), zinc gluconate), copper gluconate, iodine, boron and various vitamins; second pacakge include esssential fatty acid; dosage form |
| 01/25/2011 | US7875290 Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 01/25/2011 | US7875289 Compositions of less immunogenic and long-circulating protein-lipid complexes |
| 01/25/2011 | US7875288 such as hemophilia, by administering lipidic nanoparticles comprising phosphatidylcholine, phosphatidylinositol and cholesterol; use when the individual has developed the side effect of antibodies to Factor VIII |
| 01/25/2011 | US7875270 Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 01/25/2011 | US7875022 Portable infusion pump and media player |
| 01/25/2011 | CA2642851C Low flush niacin formulation |
| 01/25/2011 | CA2628200C Solid pharmaceutical compositions containing pregabalin |
| 01/25/2011 | CA2594710C Topical bioadhesive formulations |
| 01/25/2011 | CA2541599C Blister pack and solid dosage form therefor |
| 01/25/2011 | CA2496540C Stable ophthalmic solution comprising latanoprost as active ingredient |
| 01/25/2011 | CA2483090C Use of therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions |
| 01/25/2011 | CA2477714C New cinnamic acid salts, processes for the preparation thereof and use thereof as medicament |
| 01/25/2011 | CA2459327C Implantable infusion device and reservoir for same |
| 01/25/2011 | CA2449066C Nicotine-containing film preparation |
| 01/25/2011 | CA2436599C Oral pharmaceutical compositions comprising polyvinylpyrrolidone (pvp) and 5-cnac |
| 01/25/2011 | CA2430857C Percutaneous absorption-type pharmaceutical preparation and process for producing the same |
| 01/25/2011 | CA2426692C Block copolymers for multifunctional self-assembled systems |
| 01/25/2011 | CA2425231C Patch and production method thereof |
| 01/25/2011 | CA2410000C Compositions and methods comprising plasmid dna for wound healing and for repairing and regenerating tissue |
| 01/25/2011 | CA2405030C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 01/25/2011 | CA2384425C Methods and compositions for delivery of pharmaceutical agents |
| 01/25/2011 | CA2369175C Methods for stabilizing liquid nutritional products and products so stabilized |
| 01/25/2011 | CA2363053C Clopidogrel bisulfate tablet formulation |
| 01/25/2011 | CA2163278C Method for production of arachidonic acid |
| 01/20/2011 | WO2011009039A2 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 01/20/2011 | WO2011008939A2 Porous-wall hollow glass microspheres as carriers for biomolecules |
| 01/20/2011 | WO2011008923A2 Olopatadine nasal spray regimen for children |
| 01/20/2011 | WO2011008770A2 Methods for inhibiting yellow color and peroxide formation in a composition |
| 01/20/2011 | WO2011008674A1 Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof |
| 01/20/2011 | WO2011008298A2 Novel axomadol dosage forms |
| 01/20/2011 | WO2011008193A1 Fusidic acid dosing regimens for treatment of bacterial infections |
| 01/20/2011 | WO2011008183A1 Trimetazidine dihydrochloride-containing medication in the form of an extended-release matrix tablet (variants) and methods for preparing same (variants) |
| 01/20/2011 | WO2011008001A2 Antihypertensive composition containing a ginsenoside-enriched fraction |
| 01/20/2011 | WO2011007893A1 Eye drop with difluprednate for macular edema treatment |
| 01/20/2011 | WO2011007838A1 Benzimidazole-based injection solution |
| 01/20/2011 | WO2011007824A1 Antitumor composition and method for treating tumors |
| 01/20/2011 | WO2011007795A1 Composition for inhibiting the expression of target gene |
| 01/20/2011 | WO2011007792A1 Enzyme composition |
| 01/20/2011 | WO2011007552A1 Bad breath-removing agent |
| 01/20/2011 | WO2011007551A1 Sugar alcohol-containing antibacterial agent for inhibiting proliferation of periodontal disease-causing bacteria |
| 01/20/2011 | WO2011007353A1 Sustained-release drug carrier composition |
| 01/20/2011 | WO2011007327A2 Suspension for therapeutic use and device for delivering said suspension |
| 01/20/2011 | WO2011007153A1 Improvements in and relating to colon cleansing compositions |
| 01/20/2011 | WO2011007082A1 Emulsion activatable by ultrasounds and method for producing same |
| 01/20/2011 | WO2011007007A1 Orally administered bacteria as vehicles for systemic delivery of agents |
| 01/20/2011 | WO2011006994A1 Hdl comprising a therapeutic agent and use in therapy |
| 01/20/2011 | WO2011006670A1 Separating layers for pharmaceutical preparations to prevent interactions between medicinal drugs and pharmaceutical-technological adjuvants |
| 01/20/2011 | WO2011006611A2 Pellets formulation |
| 01/20/2011 | WO2011006596A2 Aqueous solution and gelatinized composition comprising a phosphodiesterase-5 inhibitor and corresponding methods and use |
| 01/20/2011 | WO2011006510A1 Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines |
| 01/20/2011 | WO2011006504A2 Treatment of hyperproliferative conditions |
| 01/20/2011 | WO2011006453A1 Compound lipid based on pentaerythritol, intermediates, preparation method and use thereof |
| 01/20/2011 | WO2010116385A3 Pharmaceutical compositions for alleviating unpleasant taste |
| 01/20/2011 | WO2010111403A3 Probablistic pharmacokinetic and pharmacodynamic modeling |
| 01/20/2011 | WO2010105995A3 Zoo-technical drug delivery device |
| 01/20/2011 | WO2010104584A3 Articles and methods of treating vascular conditions |
| 01/20/2011 | WO2010100506A3 Delivery system with scaffolds |
| 01/20/2011 | WO2010099552A3 Devices, systems and methods for magnetic-assisted therapeutic agent delivery |
| 01/20/2011 | WO2010095840A3 Donepezil resin complex |
| 01/20/2011 | WO2010092088A3 Use of hydrophobin as a spreading agent |
| 01/20/2011 | WO2010090502A3 External use composition containing cholecalciferol or its derivative for treating skin disorders |
| 01/20/2011 | WO2010059534A3 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof |
| 01/20/2011 | WO2010035245A3 Extended release dosage form of ropinirole |